Opportunities for Enterprise | School of Biotechnology
Opportunities for Enterprise
There are many ways for enterprise partners to engage with the research experts in the School of Biotechnology. Find further information below regarding collaborations or consultancy.
Collaboration Opportunities
Please contact any of the PIs below to find out further information.
The specialists in the Health Technologies and The Healthy and Ageing Society Hub’s business development team can arrange ready access to DCU’s patent portfolio and can help to create interactions with DCU researchers that are tailored to fit the specific needs of individual enterprises. For further information and opportunities for collaboration contact:
- Prof Christine Loscher, Director, Health Technologies and Healthy & Ageing Society, Research & Enterprise Hub: Tel +353 1 700 5244. Email: christine.loscher@dcu.ie
- Emma O’Neill, Business Development Manager, DCU Invent: Tel + 353 1 7007741 Email: emma.oneill@invent.dcu.ie
- Fiona Brennan, Senior Research Support Officer, DCU Research & Innovation: Tel + 353 1 7007816 Email: fiona.brennan@dcu.ie
Dr. Phil Cummins: Availability (within the PI Lab) of an in vitro blood-brain barrier (BBB) model for pre-clinical assessment of food/drug compounds
Dr. Michael Freeley led a collaborative project with an international life sciences company where he performed the first RNAi library screens in primary human T-cells using their proprietary self-delivering RNAi technology (Freeley et al. 2015, J. Biomolecular Screening). He has also carried out contract research for a pharmaceutical company to screen small molecule drugs to evaluate their anti-inflammatory potential in in-vitro T-cell assays.
Further information about collaborative opportunities in DCU can be found HERE.
Consultancy
The specialists in the Health Technologies and The Healthy and Ageing Society Hub’s business development team can arrange ready access to DCU’s patent portfolio and can help to create interactions with DCU researchers that are tailored to fit the specific needs of individual enterprises. For further information and opportunities for collaboration contact:
- Prof Christine Loscher, Director, Health Technologies and Healthy & Ageing Society, Research & Enterprise Hub: Tel +353 1 700 5244. Email: christine.loscher@dcu.ie
- Emma O’Neill, Business Development Manager, DCU Invent: Tel + 353 1 7007741 Email: emma.oneill@invent.dcu.ie
- Fiona Brennan, Senior Research Support Officer, DCU Research & Innovation: Tel + 353 1 7007816 Email: fiona.brennan@dcu.ie
Prof. Paul Cahill: Vascular Biology, Stem Cell Biology, MechanoBiology, Cytomechanics, Pharmacology, Cardiovascular Disease. Prof. Cahill has been a consultant for Medtronic AVE, Bayer AG, IDA and SFI.
Dr. Jenny Lawler: Specification of membrane based solutions for water and wastewater treatment, development of tailored novel membranes for protein separation or environmental application.
Dr. Anne Parle-McDermott: Folic acid nutrition, Functional Genetics, PCR based assays.
Dr. Michael Freeley: RNAi library screens in primary human T-cells using their proprietary self-delivering RNAi technology, screening small molecule drugs to evaluate their anti-inflammatory potential in in-vitro T-cell assays.
CASE STUDIES:
Prof. Paul Cahill has previously worked with General Electric, Bristol Meyers Squibb, Medtronic AVE, Bayer Healthcare, Elan Pharmaceuticals Inc, Solvotrin Innovations Ltd.
Prof. Christine Loscher has significant partnerships with Irish biotech companies and Global food companies in the area of immunomodulation for health benefit.
Dr. Jenny Lawler: has partnered with companies including Alltech and Oxymem in the development of waste and water management soloutions.
Dr. Dermot Walls has worked with GlaxoSmithKline Plc., Proctor and Gamble, Enfer Group and Alltech (Ireland) on a variety of projects. He is a judge at the BT Young Scientist and Technology competition.
SPIN OUTS:
Further information:
DCU INVENT – Innovation & Enterprise
Health Technologies and the Healthy &Ageing Society